A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

1,493

Participants

Timeline

Start Date

March 1, 2011

Primary Completion Date

March 1, 2012

Study Completion Date

April 19, 2012

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GSK573719/GW642444 125/25mcg

125/25mcg

DRUG

GSK573719 125mcg

125mcg

DRUG

GW642444 25mcg

25mcg

DRUG

Placebo only

Placebo

Trial Locations (157)

1109

GSK Investigational Site, Quezon City

1319

GSK Investigational Site, Bekkestua

1529

GSK Investigational Site, Budapest

1800

GSK Investigational Site, Marikina City

2040

GSK Investigational Site, Kløfta

2045

GSK Investigational Site, Törökbálint

2100

GSK Investigational Site, Gödöllő

2400

GSK Investigational Site, Copenhagen

2408

GSK Investigational Site, Elverum

2610

GSK Investigational Site, Roedovre

2650

GSK Investigational Site, Edegem

GSK Investigational Site, Hvidovre

2660

GSK Investigational Site, Balassagyarmat

3019

GSK Investigational Site, Marilao, Bulacan

3200

GSK Investigational Site, Gyöngyös

3600

GSK Investigational Site, Genk

3800

GSK Investigational Site, Szikszó

3980

GSK Investigational Site, Sátoraljaújhely

4000

GSK Investigational Site, Liège

GSK Investigational Site, Roskilde

4005

GSK Investigational Site, Stavanger

4032

GSK Investigational Site, Debrecen

4114

GSK Investigational Site, Dasmariñas, Cavite

4400

GSK Investigational Site, Nyíregyháza

4700

GSK Investigational Site, Næstved

5000

GSK Investigational Site, Odense C

5017

GSK Investigational Site, Bergen

6000

GSK Investigational Site, Cebu City

6772

GSK Investigational Site, Deszk

7011

GSK Investigational Site, Trondheim

7027

GSK Investigational Site, Trondheim

8005

GSK Investigational Site, Bodø

8500

GSK Investigational Site, Kortrijk

8582

GSK Investigational Site, Farkasgyepű

9100

GSK Investigational Site, Aalborg

9300

GSK Investigational Site, Aalst

9700

GSK Investigational Site, Szombathely

10117

GSK Investigational Site, Tallinn

GSK Investigational Site, Berlin

10138

GSK Investigational Site, Tallinn

10367

GSK Investigational Site, Berlin

10787

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

13581

GSK Investigational Site, Berlin

14059

GSK Investigational Site, Berlin

20246

GSK Investigational Site, Hamburg

20253

GSK Investigational Site, Hamburg

21502

GSK Investigational Site, Geesthacht

22143

GSK Investigational Site, Hamburg

23225

GSK Investigational Site, Richmond

28207

GSK Investigational Site, Charlotte

29303

GSK Investigational Site, Spartanburg

29379

GSK Investigational Site, Union

29615

GSK Investigational Site, Greenville

29640

GSK Investigational Site, Easley

31059

GSK Investigational Site, Toulouse

32405

GSK Investigational Site, Panama City

32720

GSK Investigational Site, DeLand

32822

GSK Investigational Site, Orlando

33765

GSK Investigational Site, Clearwater

35501

GSK Investigational Site, Jasper

37044

GSK Investigational Site, Tours

39112

GSK Investigational Site, Magdeburg

44316

GSK Investigational Site, Rakvere

48152

GSK Investigational Site, Livonia

51014

GSK Investigational Site, Tartu

51069

GSK Investigational Site, Cologne

51092

GSK Investigational Site, Reims

55441

GSK Investigational Site, Plymouth

59690

GSK Investigational Site, Vieux-Condé

60596

GSK Investigational Site, Frankfurt am Main

61037

GSK Investigational Site, Kharkiv

61124

GSK Investigational Site, Kharkiv

63110

GSK Investigational Site, Rodgau

63263

GSK Investigational Site, Neu-Isenburg

63571

GSK Investigational Site, Gelnhausen

65013

GSK Investigational Site, Tarbes

66000

GSK Investigational Site, Perpignan

66606

GSK Investigational Site, Topeka

68506

GSK Investigational Site, Lincoln

69035

GSK Investigational Site, Zaporizhia

69317

GSK Investigational Site, Lyon

76018

GSK Investigational Site, Ivano-Frankivsk

80010

GSK Investigational Site, Pärnu

80809

GSK Investigational Site, Munich

82017

GSK Investigational Site, Montauban

83000

GSK Investigational Site, Toulon

83099

GSK Investigational Site, Donetsk

85006

GSK Investigational Site, Phoenix

89407

GSK Investigational Site, Dillingen an der Donau

90095

GSK Investigational Site, Los Angeles

90502

GSK Investigational Site, Torrance

GSK Investigational Site, Haapsalu

90822

GSK Investigational Site, Long Beach

91126

GSK Investigational Site, Schwabach

92117

GSK Investigational Site, San Diego

92506

GSK Investigational Site, Riverside

94304

GSK Investigational Site, Palo Alto

94550

GSK Investigational Site, Künzing

95043

GSK Investigational Site, Simferopol

92103-8415

GSK Investigational Site, San Diego

08003

GSK Investigational Site, Cherry Hill

06000

GSK Investigational Site, Nice

01307

GSK Investigational Site, Dresden

04109

GSK Investigational Site, Leipzg

04103

GSK Investigational Site, Leipzig

04626

GSK Investigational Site, Schmölln

454-8502

GSK Investigational Site, Aichi

455-8530

GSK Investigational Site, Aichi

457-8510

GSK Investigational Site, Aichi

296-8602

GSK Investigational Site, Chiba

802-0052

GSK Investigational Site, Fukuoka

811-3195

GSK Investigational Site, Fukuoka

814-0180

GSK Investigational Site, Fukuoka

832-0059

GSK Investigational Site, Fukuoka

070-8644

GSK Investigational Site, Hokkaido

319-1113

GSK Investigational Site, Ibaraki

252-0001

GSK Investigational Site, Kanagawa

989-1253

GSK Investigational Site, Miyagi

714-0081

GSK Investigational Site, Okayama

596-8501

GSK Investigational Site, Osaka

434-8511

GSK Investigational Site, Shizuoka

171-0014

GSK Investigational Site, Tokyo

194-0023

GSK Investigational Site, Tokyo

204-8585

GSK Investigational Site, Tokyo

1815 JD

GSK Investigational Site, Alkmaar

7609 PP

GSK Investigational Site, Almelo

1311 RL

GSK Investigational Site, Almere Stad

6191 JW

GSK Investigational Site, Beek

6716 RP

GSK Investigational Site, Ede

5623 EJ

GSK Investigational Site, Eindhoven

7513 ER

GSK Investigational Site, Enschede

9728 NP

GSK Investigational Site, Groningen

5707 HA

GSK Investigational Site, Helmond

1624 NP

GSK Investigational Site, Hoorn

7651 JH

GSK Investigational Site, Tubbergen

5504 DB

GSK Investigational Site, Veldhoven

7207 AE

GSK Investigational Site, Zutphen

N-2020

GSK Investigational Site, Skedsmokorset

085 01

GSK Investigational Site, Bardejov

066 01

GSK Investigational Site, Humenné

058 01

GSK Investigational Site, Poprad

050 01

GSK Investigational Site, Revúca

052 01

GSK Investigational Site, Spišská Nová Ves

952 01

GSK Investigational Site, Vráble

SE-412 63

GSK Investigational Site, Gothenburg

SE-413 45

GSK Investigational Site, Gothenburg

SE-236 32

GSK Investigational Site, Höllviken

SE-582 16

GSK Investigational Site, Linköping

SE-971 89

GSK Investigational Site, Luleå

SE-221 85

GSK Investigational Site, Lund

SE-211 52

GSK Investigational Site, Malmo

SE-111 57

GSK Investigational Site, Stockholm

SE-113 61

GSK Investigational Site, Stockholm

SE-162 68

GSK Investigational Site, Vällingby

03680

GSK Investigational Site, Kiev

GSK Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01313637 - A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD | Biotech Hunter | Biotech Hunter